Whether you celebrate Easter or not, most aisles in your local grocery store are filled with highly processed candies this time of year that are unhealthy. Before you purchase a bag of candy take a look at some healthier treats.
Take Action to Save Medicare Benefits for People with Rheumatic Diseases
Medicare beneficiaries, and the medical professionals
who care for them, face significant complexities in managing care and
treatment options associated with rheumatic conditions, such as
scleroderma/systemic sclerosis, lupus, and rheumatoid arthritis. Newly proposed
regulations will make it more difficult for rheumatologists to prescribe
certain medications that can be life-improving and, in some cases, life-saving,
to people with rheumatic conditions who receive Medicare benefits. Such
medications include biologics, which are currently covered under Medicare Part
B, but may not be covered under the proposed new regulations. The
Coalition of State Rheumatology Organizations is asking for people with
rheumatic conditions such as scleroderma and their families/caregivers to join
them in the fight to preserve Medicare beneficiaries access to all treatments
that healthcare professionals deem appropriate.
Our Inspire support community is now over 21,000 members strong! Inspire.com was created because we all need a safe place to discuss our heath. There are now over 700,000 patients and caregivers on Inspire.com, interacting in several hundred communities - many of which are dedicated to people affected by chronic, invisible and/or rare disorders.
It's official. Spring is here. Everything outside looks fresh and clean. It is time to get inspired and make the inside of your home look and smell the same way. Making your own cleaners is a great way to save money and stops toxins from entering your home.
Persons with Systemic Sclerosis Needed for Research Study
Researchers from the Universities of New Mexico and Michigan and the Medical University of South Carolina are seeing participants for a study to evaluate a self-management program for people with systemic sclerosis. For more information about the study and eligibility requirements please contact Jennifer Serrano at email@example.com or 734.232.2119
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.